Cargando…
Apparent histological changes of adipocytes after treatment with CL 316,243, a β-3-adrenergic receptor agonist
BACKGROUND AND OBJECTIVES: The objective of this experiment was to study the effect of CL 316,243 (CL) (a highly selective β3-adrenergic receptor agonist) on cellular changes occurring in retroperitoneal white adipose tissue (RWAT) of lean and obese rats. METHODS: Ten-month-old lean and obese Zucker...
Autores principales: | Ghorbani, Masoud, Teimourian, Shahram, Farzad, Reza, Asl, Nabiollah Namvar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334338/ https://www.ncbi.nlm.nih.gov/pubmed/25709398 http://dx.doi.org/10.2147/DDDT.S73891 |
Ejemplares similares
-
CL316,243, a β3-adrenergic receptor agonist, induces muscle hypertrophy and increased strength
por: Puzzo, Daniela, et al.
Publicado: (2016) -
Anti Diabetic effect of CL 316,243 (A β3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-α) Expression
por: Ghorbani, Masoud, et al.
Publicado: (2012) -
The glucose lowering effects of CL 316,243 dissipate with repeated use and are rescued bycilostamide
por: Medak, Kyle D., et al.
Publicado: (2022) -
Adipose tissue hyaluronan production improves systemic glucose homeostasis and primes adipocytes for CL 316,243-stimulated lipolysis
por: Zhu, Yi, et al.
Publicado: (2021) -
The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice
por: Kumar, Amit, et al.
Publicado: (2015)